U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07415304) titled 'A Phase 1 Study of ISM4808 in Healthy Adult Subjects' on Jan. 26.
Brief Summary: This is a Phase I, randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), food effect, and QTc effects of single and multiple ascending oral doses of ISM4808 in healthy adult subjects.
Study Start Date: Feb. 13
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: ISM4808
ISM4808 administered orally as capsules in single ascending dose and multiple ascending dose regimens, with flexible dosing schedules based on emerging safety and phar...